BLACK DIAMOND THERAPEUTICS I (BDTX) Stock Balance Sheet
NASDAQ:BDTX - Nasdaq - US09203E1055 - Common Stock
| MRQ (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 23.43M | 56.22M | 34.30M | 65.80M | 34.60M | |||
| Marketable Securities | 89.26M | 75.18M | 88.50M | 144.00M | 280.50M | |||
| Other Current Assets | 2.86M | 2.63M | 4.90M | 5.90M | 4.50M | |||
| Total Current Assets | 115.54M | 134.03M | 127.70M | 215.70M | 319.60M | |||
| Non-Current Assets | ||||||||
| PPE Net | 21.24M | 23.71M | 27.40M | 30.70M | 8.80M | |||
| Other Non-Current Assets | 1.12M | 823.00K | 1.20M | 1.20M | 1.30M | |||
| Total Non-Current Assets | 22.36M | 24.53M | 28.60M | 32.00M | 10.10M | |||
| TOTAL ASSETS | 137.90M | 158.57M | 156.30M | 247.70M | 329.70M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 18.83M | 17.32M | 13.40M | 19.50M | 11.70M | |||
| Accounts Payable | 1.97M | 2.32M | 1.90M | 4.10M | 2.50M | |||
| Other Current Liabilities | N/A | N/A | N/A | N/A | N/A | |||
| Total Current Liabilities | 20.80M | 19.65M | 15.30M | 23.60M | 14.20M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 19.67M | 22.18M | 25.30M | 28.10M | 7.70M | |||
| Total Non-Current Liabilities | 19.67M | 22.18M | 25.30M | 28.20M | 7.70M | |||
| TOTAL LIABILITIES | 40.47M | 41.83M | 40.60M | 51.80M | 21.90M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -471.12M | -417.43M | -335.00M | -243.80M | -118.20M | |||
| Additional Paid In Capital | 568.43M | 534.19M | 452.50M | 440.10M | 425.40M | |||
| Common Shares | 7.00K | 7.00K | 0.00 | 0.00 | 0.00 | |||
| Other Shareholders' Equity | 107.00K | N/A | N/A | -400.00K | 600.00K | |||
| Shares Outstanding | 56.52M | 51.65M | 36.40M | 36.20M | 36.10M | |||
| Tangible Book Value per Share | 1.72 | 2.26 | 3.18 | 5.41 | 8.53 | |||
| Total Shareholders' Equity | 97.43M | 116.74M | 115.70M | 195.90M | 307.80M | |||
| TOTAL LIABILITIES AND EQUITY | 137.90M | 158.57M | 156.30M | 247.70M | 329.70M | |||
| Statistics | ||||||||
| Current Ratio | 5.55 | 6.82 | 8.35 | 9.14 | 22.51 | |||
| Return On Assets (ROA) | -53.01% | -51.99% | -58.33% | -50.71% | -20.40% | |||
| Return On Equity (ROE) | -75.03% | -70.62% | -78.80% | -64.11% | -21.85% | |||
All data in USD , ROIC based on taxRate of 0.21